{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:44:19Z","timestamp":1792172659342,"version":"4.4.0"},"reference-count":111,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/wco.0b013e328347b307","type":"journal-article","created":{"date-parts":[[2011,5,14]],"date-time":"2011-05-14T07:07:03Z","timestamp":1305356823000},"page":"346-353","source":"Crossref","is-referenced-by-count":95,"title":["Movement disorders in paraneoplastic and autoimmune disease"],"prefix":"10.1097","volume":"24","author":[{"given":"Jessica","family":"Panzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Dalmau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210206","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/mds.22658","article-title":"Paraneoplastic movement disorders.","volume":"24","author":"Grant","year":"2009","journal-title":"Mov Disord"},{"key":"R2-7-20210206","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.seminoncol.2006.03.008","article-title":"Paraneoplastic syndromes affecting the nervous system.","volume":"33","author":"Darnell","year":"2006","journal-title":"Semin Oncol"},{"key":"R3-7-20210206","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/jnnp.2008.159483","article-title":"Cerebrospinal fluid study in paraneoplastic syndromes.","volume":"81","author":"Psimaras","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R4-7-20210206","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes.","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R5-7-20210206","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/mds.10616","article-title":"Paraneoplastic movement disorder in a patient with non-Hodgkins lymphoma and CRMP-5 autoantibody.","volume":"18","author":"Samii","year":"2003","journal-title":"Mov Disord"},{"key":"R6-7-20210206","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.10178","article-title":"Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma.","volume":"51","author":"Vernino","year":"2002","journal-title":"Ann Neurol"},{"key":"R7-7-20210206","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","article-title":"CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity.","volume":"49","author":"Yu","year":"2001","journal-title":"Ann Neurol"},{"key":"R8-7-20210206","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/mds.20570","article-title":"Paraneoplastic chorea with leukoencephalopathy presenting with obsessive-compulsive and behavioral disorder.","volume":"20","author":"Muehlschlegel","year":"2005","journal-title":"Mov Disord"},{"key":"R9-7-20210206","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/jnnp.2007.138016","article-title":"Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2CRMP5 antibodies.","volume":"80","author":"Honnorat","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R10-7-20210206","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1071-9091(02)00004-9","article-title":"Sydenhams chorea: not gone and not forgotten.","volume":"10","author":"Bonthius","year":"2003","journal-title":"Semin Pediatr Neurol"},{"key":"R11-7-20210206","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1542\/peds.2005-1573","article-title":"Sydenhams chorea in western Pennsylvania.","volume":"117","author":"Zomorrodi","year":"2006","journal-title":"Pediatrics"},{"key":"R12-7-20210206","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2009.12.004","article-title":"The prevalence of neuropsychiatric disorders in Sydenhams chorea.","volume":"42","author":"Ridel","year":"2010","journal-title":"Pediatr Neurol"},{"key":"R13-7-20210206","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/mds.870120512","article-title":"Chorea in fifty consecutive patients with rheumatic fever.","volume":"12","author":"Cardoso","year":"1997","journal-title":"Mov Disord"},{"key":"R14-7-20210206","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s00234-003-0999-8","article-title":"Clinical, laboratory, psychiatric and magnetic resonance findings in patients with Sydenham chorea.","volume":"45","author":"Faustino","year":"2003","journal-title":"Neuroradiology"},{"key":"R15-7-20210206","first-page":"867","article-title":"Are all recurrences of pure Sydenham chorea true recurrences of acute rheumatic fever J P","volume":"107","author":"Berrios","year":"1985","journal-title":"ediatr"},{"key":"R16-7-20210206","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-5728(03)00012-2","article-title":"CSF and serum immune parameters in Sydenhams chorea: evidence of an autoimmune syndrome J N","volume":"136","author":"Church","year":"2003","journal-title":"euroimmunol"},{"key":"R17-7-20210206","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1172\/JCI108714","article-title":"Antibodies to human caudate nucleus neurons in Huntingtons chorea.","volume":"59","author":"Husby","year":"1977","journal-title":"J Clin Invest"},{"key":"R18-7-20210206","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00415-009-5076-8","article-title":"A preliminary study of the frequency of antibasal ganglia antibodies and streptococcal infection in attention deficithyperactivity disorder.","volume":"256","author":"Sanchez-Carpintero","year":"2009","journal-title":"J Neurol"},{"key":"R19-7-20210206","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.4049\/jimmunol.178.11.7412","article-title":"Tubulin is a neuronal target of autoantibodies in Sydenhams chorea.","volume":"178","author":"Kirvan","year":"2007","journal-title":"J Immunol"},{"key":"R20-7-20210206","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.4049\/jimmunol.151.5.2820","article-title":"Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain.","volume":"151","author":"Bronze","year":"1993","journal-title":"J Immunol"},{"key":"R21-7-20210206","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/08916930500484757","article-title":"Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenhams chorea.","volume":"39","author":"Kirvan","year":"2006","journal-title":"Autoimmunity"},{"key":"R22-7-20210206","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nm892","article-title":"Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea.","volume":"9","author":"Kirvan","year":"2003","journal-title":"Nat Med"},{"key":"R24-7-20210206","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/1531-8257(199909)14:5<805::AID-MDS1013>3.0.CO;2-P","article-title":"Persistent Sydenhams chorea.","volume":"14","author":"Cardoso","year":"1999","journal-title":"Mov Disord"},{"key":"R25-7-20210206","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archneur.61.8.1261","article-title":"Recurrence of Sydenham chorea: implications for pathogenesis.","volume":"61","author":"Korn-Lubetzki","year":"2004","journal-title":"Arch Neurol"},{"key":"R26-7-20210206","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/08830738050200050601","article-title":"Treatment of Sydenhams chorea with intravenous immunoglobulin, plasma exchange, or prednisone.","volume":"20","author":"Garvey","year":"2005","journal-title":"J Child Neurol"},{"key":"R27-7-20210206","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1212\/WNL.40.7.1140","article-title":"Effectiveness of sodium valproate in the treatment of Sydenhams chorea.","volume":"40","author":"Daoud","year":"1990","journal-title":"Neurology"},{"key":"R28-7-20210206","first-page":"1215","article-title":"The use of haloperidol and valproate in children with Sydenham chorea.","volume":"35","author":"Ronchezel","year":"1998","journal-title":"Indian Pediatr"},{"key":"R29-7-20210206","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/08916930410001708706","article-title":"Antiphospholipid (Hughes) syndrome.","volume":"37","author":"Khamashta","year":"2004","journal-title":"Autoimmunity"},{"key":"R30-7-20210206","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/ard.47.8.681","article-title":"Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies.","volume":"47","author":"Khamashta","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"R31-7-20210206","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00005792-199705000-00006","article-title":"Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature.","volume":"76","author":"Cervera","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"R32-7-20210206","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.3899\/jrheum.080268","article-title":"Antiphospholipid antibody-associated chorea.","volume":"35","author":"Orzechowski","year":"2008","journal-title":"J Rheumatol"},{"key":"R33-7-20210206","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1191\/096120399678847524","article-title":"Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes.","volume":"8","author":"Chapman","year":"1999","journal-title":"Lupus"},{"key":"R34-7-20210206","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.semarthrit.2006.11.003","article-title":"Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome.","volume":"36","author":"Zandman-Goddard","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"R35-7-20210206","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"R36-7-20210206","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.0b013e3181f8831a","article-title":"Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus.","volume":"75","author":"Johnson","year":"2010","journal-title":"Neurology"},{"key":"R37-7-20210206","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1212\/01.wnl.0000278388.90370.c3","article-title":"Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.","volume":"70","author":"Iizuka","year":"2008","journal-title":"Neurology"},{"key":"R38-7-20210206","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"R39-7-20210206","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/mds.22073","article-title":"The distinctive movement disorder of ovarian teratoma-associated encephalitis.","volume":"23","author":"Kleinig","year":"2008","journal-title":"Mov Disord"},{"key":"R40-7-20210206","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly nonparaneoplastic disorder of both sexes.","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"R41-7-20210206","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11060-007-9372-9","article-title":"Clinical analysis of paraneoplastic encephalitis associated with ovarian teratoma.","volume":"84","author":"Tonomura","year":"2007","journal-title":"J Neurooncol"},{"key":"R42-7-20210206","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11060-006-9200-7","article-title":"EFA6A-like antibodies in paraneoplastic encephalitis associated with immature ovarian teratoma: a case report.","volume":"81","author":"Koide","year":"2007","journal-title":"J Neurooncol"},{"key":"R43-7-20210206","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1684\/epd.2009.0266","article-title":"Complex partial status epilepticus revealing anti-NMDA receptor encephalitis.","volume":"11","author":"Bayreuther","year":"2009","journal-title":"Epileptic Disord"},{"key":"R44-7-20210206","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis.","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"R45-7-20210206","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1136\/jnnp.2008.147611","article-title":"Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis.","volume":"79","author":"Eker","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R46-7-20210206","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents.","volume":"66","author":"Florance","year":"2009","journal-title":"Ann Neurol"},{"key":"R47-7-20210206","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"R48-7-20210206","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.yebeh.2010.11.020","article-title":"Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis.","volume":"20","author":"Kirkpatrick","year":"2011","journal-title":"Epilepsy Behav"},{"key":"R49-7-20210206","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ncpneuro0493","article-title":"A patient with encephalitis associated with NMDA receptor antibodies.","volume":"3","author":"Sansing","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"R50-7-20210206","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.21807","article-title":"N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica.","volume":"66","author":"Dale","year":"2009","journal-title":"Ann Neurol"},{"key":"R51-7-20210206","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1212\/01.wnl.0000336648.43562.59","article-title":"Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab.","volume":"71","author":"Ishiura","year":"2008","journal-title":"Neurology"},{"key":"R52-7-20210206","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1212\/WNL.0b013e3181dd41a1","article-title":"Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis.","volume":"74","author":"Wong-Kisiel","year":"2010","journal-title":"Neurology"},{"key":"R53-7-20210206","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.1288","article-title":"Molecular and clinical diversity in paraneoplastic immunity to Ma proteins.","volume":"50","author":"Rosenfeld","year":"2001","journal-title":"Ann Neurol"},{"key":"R54-7-20210206","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1212\/WNL.52.4.864","article-title":"Neuro-ophthalmologic manifestations of a paraneoplastic syndrome and testicular carcinoma.","volume":"52","author":"Bennett","year":"1999","journal-title":"Neurology"},{"key":"R55-7-20210206","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis.","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain"},{"key":"R56-7-20210206","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.2007.118588","article-title":"Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: twenty-two newly diagnosed patients and review of previous cases.","volume":"79","author":"Hoffmann","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R57-7-20210206","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/ncpneuro0287","article-title":"Anti-Ma2-associated encephalitis with normal FDG-PET: a case of pseudo-Whipples disease.","volume":"2","author":"Castle","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"R58-7-20210206","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1212\/01.wnl.0000252379.81933.80","article-title":"Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis.","volume":"68","author":"Mathew","year":"2007","journal-title":"Neurology"},{"key":"R59-7-20210206","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1634\/theoncologist.11-3-292","article-title":"Managing paraneoplastic neurological disorders.","volume":"11","author":"de Beukelaar","year":"2006","journal-title":"Oncologist"},{"key":"R60-7-20210206","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11940-009-0007-7","article-title":"Treatment of anti-Ma2Ta paraneoplastic syndrome.","volume":"11","author":"Kraker","year":"2009","journal-title":"Curr Treat Options Neurol"},{"key":"R61-7-20210206","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s004150050425","article-title":"The stiff man and stiff man plus syndromes.","volume":"246","author":"Brown","year":"1999","journal-title":"J Neurol"},{"key":"R62-7-20210206","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1212\/01.wnl.0000196488.87746.7b","article-title":"Paraneoplastic encephalomyelitis associated with pancreatic tumor and anti-GAD antibodies.","volume":"66","author":"Hernandez-Echebarria","year":"2006","journal-title":"Neurology"},{"key":"R63-7-20210206","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"key":"R64-7-20210206","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1365-2362.2010.02340.x","article-title":"A critical update on the immunopathogenesis of Stiff Person syndrome.","volume":"40","author":"Alexopoulos","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"R65-7-20210206","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/archneur.56.2.172","article-title":"Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors.","volume":"56","author":"Antoine","year":"1999","journal-title":"Arch Neurol"},{"key":"R66-7-20210206","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00415-002-0677-5","article-title":"Antiamphiphysin associated limbic encephalitis: a paraneoplastic presentation of small-cell lung carcinoma.","volume":"249","author":"Dorresteijn","year":"2002","journal-title":"J Neurol"},{"key":"R67-7-20210206","first-page":"661","article-title":"Progressive encephalomyelitis with rigidity associated with antiamphiphysin antibodies.","volume":"75","author":"Ishii","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R68-7-20210206","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ana.20529","article-title":"Amphiphysin autoimmunity: paraneoplastic accompaniments.","volume":"58","author":"Pittock","year":"2005","journal-title":"Ann Neurol"},{"key":"R69-7-20210206","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1212\/01.wnl.0000327342.58936.e0","article-title":"Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease.","volume":"71","author":"Murinson","year":"2008","journal-title":"Neurology"},{"key":"R70-7-20210206","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.21123","article-title":"Effects of antiglutamic acid decarboxylase antibodies associated with neurological diseases.","volume":"61","author":"Manto","year":"2007","journal-title":"Ann Neurol"},{"key":"R71-7-20210206","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1093\/brain\/awq253","article-title":"Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition.","volume":"133","author":"Geis","year":"2010","journal-title":"Brain"},{"key":"R72-7-20210206","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1093\/brain\/awl245","article-title":"Autoimmunity to GABAA-receptor-associated protein in Stiff-person syndrome.","volume":"129","author":"Raju","year":"2006","journal-title":"Brain"},{"key":"R74-7-20210206","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody.","volume":"71","author":"Hutchinson","year":"2008","journal-title":"Neurology"},{"key":"R75-7-20210206","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa01167","article-title":"High-dose intravenous immune globulin for Stiff-person syndrome.","volume":"345","author":"Dalakas","year":"2001","journal-title":"N Engl J Med"},{"key":"R76-7-20210206","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11940-003-0024-x","article-title":"Stiff-person syndrome.","volume":"5","author":"Vasconcelos","year":"2003","journal-title":"Curr Treat Options Neurol"},{"key":"R77-7-20210206","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS.","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"R78-7-20210206","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12311-009-0128-2","article-title":"Paraneoplastic cerebellar degeneration mimicking acute postinfectious cerebellitis.","volume":"8","author":"Karmon","year":"2009","journal-title":"Cerebellum"},{"key":"R79-7-20210206","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1212\/WNL.55.5.713","article-title":"Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies.","volume":"55","author":"Rojas","year":"2000","journal-title":"Neurology"},{"key":"R80-7-20210206","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/01.WNL.0000041495.87539.98","article-title":"Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkins disease.","volume":"60","author":"Bernal","year":"2003","journal-title":"Neurology"},{"key":"R81-7-20210206","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.59.5.764","article-title":"PQ type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer.","volume":"59","author":"Graus","year":"2002","journal-title":"Neurology"},{"key":"R83-7-20210206","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00415-009-5262-8","article-title":"Antineuronal antibodies in sporadic late-onset cerebellar ataxia.","volume":"257","author":"Burk","year":"2010","journal-title":"J Neurol"},{"key":"R84-7-20210206","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM200001063420104","article-title":"Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor.","volume":"342","author":"Sillevis","year":"2000","journal-title":"N Engl J Med"},{"key":"R85-7-20210206","first-page":"627","article-title":"Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease Arch N","volume":"67","author":"Marignier","year":"2010","journal-title":"eurol"},{"key":"R86-7-20210206","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1744-9987.2006.00348.x","article-title":"A case report of plasmapheresis in paraneoplastic cerebellar ataxia associated with anti-Tr antibody.","volume":"10","author":"Taniguchi","year":"2006","journal-title":"Ther Apher Dial"},{"key":"R87-7-20210206","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jnnp.68.4.479","article-title":"Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.","volume":"68","author":"Keime-Guibert","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R88-7-20210206","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/WCO.0b013e3280126b51","article-title":"An update on opsoclonus.","volume":"20","author":"Wong","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"R89-7-20210206","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archneur.1986.00520110055016","article-title":"Opsoclonus in adults. Report of three cases and review of the literature.","volume":"43","author":"Digre","year":"1986","journal-title":"Arch Neurol"},{"key":"R90-7-20210206","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.410290303","article-title":"Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.","volume":"29","author":"Luque","year":"1991","journal-title":"Ann Neurol"},{"key":"R91-7-20210206","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jneuroim.2008.05.033","article-title":"Autoantibodies in childhood opsoclonus-myoclonus syndrome.","volume":"201","author":"Blaes","year":"2008","journal-title":"J Neuroimmunol"},{"key":"R92-7-20210206","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1196\/annals.1423.027","article-title":"New autoantibodies in pediatric opsoclonus myoclonus syndrome.","volume":"1110","author":"Kirsten","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R93-7-20210206","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/WNL.62.9.1526","article-title":"B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes.","volume":"62","author":"Pranzatelli","year":"2004","journal-title":"Neurology"},{"key":"R94-7-20210206","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10875-009-9335-3","article-title":"Long-term cerebrospinal fluid and blood lymphocyte dynamics after rituximab for pediatric opsoclonus-myoclonus.","volume":"30","author":"Pranzatelli","year":"2010","journal-title":"J Clin Immunol"},{"key":"R95-7-20210206","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/mds.22941","article-title":"B cell depletion therapy for new-onset opsoclonus-myoclonus.","volume":"25","author":"Pranzatelli","year":"2010","journal-title":"Mov Disord"},{"key":"R96-7-20210206","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/MOP.0b013e32833fde3f","article-title":"Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome.","volume":"22","author":"Gorman","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"R97-7-20210206","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1542\/peds.2004-2377","article-title":"Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia.","volume":"116","author":"Mitchell","year":"2005","journal-title":"Pediatrics"},{"key":"R98-7-20210206","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/brain\/124.2.437","article-title":"Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.","volume":"124","author":"Bataller","year":"2001","journal-title":"Brain"},{"key":"R99-7-20210206","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1081\/CNV-120030214","article-title":"ANNA-2: an antibody associated with paraneoplastic opsoclonus in a patient with large-cell carcinoma of the lung with neuroendocrine features: correlation of clinical improvement with tumor response.","volume":"22","author":"Erlich","year":"2004","journal-title":"Cancer Invest"},{"key":"R100-7-20210206","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/awf178","article-title":"Phenotypic variants of autoimmune peripheral nerve hyperexcitability.","volume":"125","author":"Hart","year":"2002","journal-title":"Brain"},{"key":"R101-7-20210206","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","article-title":"Morvans syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels.","volume":"124","author":"Liguori","year":"2001","journal-title":"Brain"},{"key":"R102-7-20210206","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/mus.1078","article-title":"Acquired neuromyotonia and peripheral neuropathy in a patient with Hodgkins disease.","volume":"24","author":"Lahrmann","year":"2001","journal-title":"Muscle Nerve"},{"key":"R103-7-20210206","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1212\/WNL.0b013e3182061b1e","article-title":"Peripheral nerve hyperexcitability: a clinical and immunologic study of 38 patients.","volume":"76","author":"Rubio-Agusti","year":"2011","journal-title":"Neurology"},{"key":"R104-7-20210206","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"key":"R105-7-20210206","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvans syndrome and acquired neuromyotonia.","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"R107-7-20210206","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1196\/annals.1254.022","article-title":"Autoimmune disorders of neuronal potassium channels.","volume":"998","author":"Newsom-Davis","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"R108-7-20210206","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00401-001-0498-0","article-title":"Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis.","volume":"103","author":"Bernal","year":"2002","journal-title":"Acta Neuropathol (Berl)"},{"key":"R109-7-20210206","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.","volume":"124","author":"Graus","year":"2001","journal-title":"Brain"},{"key":"R110-7-20210206","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","article-title":"Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force.","volume":"18","author":"Titulaer","year":"2011","journal-title":"Eur J Neurol"},{"key":"R111-7-20210206","first-page":"732","article-title":"Paraneoplastic neurological syndromes: diagnosis and treatment.","volume":"20","author":"Graus","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"R112-7-20210206","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00415-005-0882-0","article-title":"An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes.","volume":"253","author":"Shamsili","year":"2006","journal-title":"J Neurol"},{"key":"R113-7-20210206","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1215\/S1152851703000395","article-title":"Immunomodulatory treatment trial for paraneoplastic neurological disorders.","volume":"6","author":"Vernino","year":"2004","journal-title":"Neuro-oncol"},{"key":"R114-7-20210206","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NRL.0b013e31813e34a5","article-title":"Limbic encephalitis and variants: classification, diagnosis and treatment.","volume":"13","author":"Tuzun","year":"2007","journal-title":"Neurologist"},{"key":"R115-7-20210206","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1055\/s-0030-1255223","article-title":"Update on paraneoplastic and autoimmune disorders of the central nervous system.","volume":"30","author":"Rosenfeld","year":"2010","journal-title":"Semin Neurol"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WCO.0b013e328347b307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:34:42Z","timestamp":1786044882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00019052-201108000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":111,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e328347b307","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}